Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
DR Singh Hudklinikk AS
AS
Active
Org 934468848
Smidsrødveien 6, 3120
Nøtterøy
Medical specialists activities
·
NACE 8622
Est. 2024 · 1 year old
— employees
Monitor
Share
Norway
/
Companies
/
Medical specialists activities
/
DR Singh Hudklinikk AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
11M
8M
6M
3M
0M
2024: 0M
0M
2024
2025: 9M
9M
2025
EBITDA
NOK millions
5M
4M
2M
1M
0M
2024: 0M
0M
2024
2025: 4M
4M
2025
Income statement
NOK thousands
Item
2025
2024
Revenue
8 991
0
Staff expenses
−3 094
−0
EBITDA
3 697
0
Depreciation & amort.
−480
−37
EBIT
3 216
−37
Net financials
−129
−2
Profit before tax
3 087
−39
Tax
683
−11
Net profit
2 405
−28
Balance sheet
NOK thousands
Item
2025
2024
Total assets
3 089
3 252
Equity
95
−10
Long-term debt
988
1 000
Short-term debt
2 006
2 261
Total debt
2 994
3 261
Financial ratios
5-year trend
EBITDA margin
41,1 %
This company
15,8 %
Market median
This company
Market median
160% above market
2024
2025
Equity ratio
3,1 %
This company
38,2 %
Market median
This company
Market median
92% below market
2024
2025
Return on equity
>999 %
This company
18,4 %
Market median
This company
Market median
>999% above market
2024
2025
Net profit margin
26,7 %
This company
8,1 %
Market median
This company
Market median
230% above market
2024
2025
Asset turnover
2,91×
This company
1,12×
Market median
This company
Market median
160% above market
2024
2025
Debt / equity
31,46×
This company
0,62×
Market median
This company
Market median
>999% above market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
More on DR Singh Hudklinikk AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network